Werner inhibitor (Eikon Therapeutics)

N/A

Report date: 2025/06/11 10:30:59
NME

Base Information

Drug NameWerner inhibitor (Eikon Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCleave Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEikon Therapeutics Inc
Inactive CompaniesCleave Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A